Induction of GAP-43 Modulates Neuroplasticity in PBSC (CD34+) Implanted-Parkinsonâs Model

CMUR > College of Medicine > Graduate Institute of Immunology > Journal articles > Item 310903500/4945

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/4945

Title:	Induction of GAP-43 Modulates Neuroplasticity in PBSC (CD34+) Implanted-Parkinsonâs Model
Authors:	å¾åæ(Woei-Cherng Shyu);(Kuo-wei Li);(Hsiao Fen Peng);ææ¬£æ¦®(Shinn-Zong Lin);(Ren Shyan Liu);(Hsiao Jung Wang);(Ching Yuan Su);(Yih Jing Lee);æé´»(Hung Li)*
Contributors:	é«å¸é¢åç«å¸ç ç©¶æ;ä¸åéé«ç¥ç¶é¨
Keywords:	6-OHDA lesioning;Parkinson's disease;peripheral blood stem cells;CD34;growth-associated protein 43 (GAP-43);1H-MRS;FDG-PET 6-OHDA lesioning;Parkinson's disease;peripheral blood stem cells;CD34;growth-associated protein 43 (GAP-43);1H-MRS;FDG
Date:	2009-02
Issue Date:	2009-08-20 22:28:32 (UTC+8)
Abstract:	As a result of the progressive decrease in efficacy of drugs used to treat Parkinson's disease (PD) and the rapid development of motor complications, effective alternative treatments for PD are required. In a 6-hydroxydopamine (6-OHDA)-induced Parkinson's rat model, intracerebral peripheral blood stem cell (CD34+) (PBSC) transplantation significantly protected dopaminergic neurons from 6-OHDA-induced neurotoxicity, enhanced neural repair of tyrosine hydroxylase neurons through up-regulation of Bcl-2, facilitated stem cell plasticity, and attenuated activation of microglia, in comparison with vehicle-control rats. The 6-OHDA-lesioned hemi-Parkinsonian rats receiving intrastriatal transplantation of PBSCs also showed: 1) enhanced glucose metabolism in the lesioned striatum and thalamus, demonstrated by [18F]fluoro-2-deoxyglucose positron emission tomography (FDG-PET), 2) improved neurochemical activity as shown by proton magnetic resonance spectroscopy (1H-MRS), and 3) significantly reduced rotational behavior in comparison with control lesioned rats. These observations might be explained by an up-regulation of growth-associated protein 43 (GAP-43) expression because improvements in neurological dysfunction were blocked by injection of MK-801 in the PBSC-treated group. In addition, a significant increase in neurotrophic factor expression was found in the ipsilateral hemisphere of the PBSC-treated group. In summary, this protocol may be a useful strategy for the treatment of clinical PD.
Relation:	JOURNAL OF NEUROSCIENCE RESEARCH 87(9):2020~2033
Appears in Collections:	[Graduate Institute of Immunology] Journal articles

Files in This Item:

File	Size	Format
	58Kb	Unknown	485	View/Open
Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.doc	560Kb	Microsoft Word	963	View/Open
Induction of GAP-43 modulates neuroplasticity in PBSC _CD34+_ implanted-Parkinson's model.pdf	548Kb	Adobe PDF	681	View/Open

Loading...